Arcutis Biotherapeutics, Inc.
ARQT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $7,410 | -$15,886 | -$25,060 | -$10,788 |
| Dep. & Amort. | $562 | $410 | $3,132 | $458 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $10,037 | $10,489 | $9,778 | $9,393 |
| Change in WC | -$19,944 | $5,128 | -$17,687 | -$1,567 |
| Other Non-Cash | $181 | $183 | -$543 | $1,756 |
| Operating Cash Flow | -$1,754 | $324 | -$30,380 | -$748 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$78 | -$608 | -$5,000 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$68,544 | -$33,152 | -$56,110 | -$17,399 |
| Inv. Sales/Matur. | $43,297 | $60,653 | $68,468 | $57,276 |
| Other Inv. Act. | $0 | -$10,000 | $0 | $0 |
| Investing Cash Flow | -$25,247 | $17,423 | $11,750 | $34,877 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $1,380 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $1,476 | $0 | $395 | -$97,411 |
| Financing Cash Flow | $1,476 | $1,380 | $395 | -$97,411 |
| Forex Effect | -$95 | $200 | $4 | -$234 |
| Net Chg. in Cash | -$25,620 | $19,327 | -$18,231 | -$63,516 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $73,048 | $53,721 | $71,952 | $135,468 |
| End Cash | $47,428 | $73,048 | $53,721 | $71,952 |
| Free Cash Flow | -$1,754 | $246 | -$30,988 | -$5,748 |